RESUMEN
Interleukin-21 (IL-21) is a type I cytokine produced by activated T cells that promotes cytokine production in monocytes. Monocytes are activated by Toll-like receptors (TLRs) to produce pro-inflammatory mediators. However, little is known about the regulatory effect of IL-21 on TLR-mediated inflammation in human monocytes. This study investigated the potential association between IL-21 and TLR2/4-mediated inflammation in human monocytic THP-1 cells. First, the expression of the IL-21 receptor (IL-21R) in human monocytic THP-1 cells was examined by flow cytometry. Then, THP-1 cells were treated with either the TLR2 ligand peptidoglycan (PGN) or the TLR4 ligand lipopolysaccharide (LPS) with or without IL-21. Then, the production of several cytokines (IL-6, IL-8, TNF-α, IFN-γ and IL-10), expression of TLR2/4, and activation of the downstream signaling pathways of mitogen-activated protein kinase (MAPK), Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3), phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt), and nuclear factor-kappa B (NF-κB) were determined. We found that IL-21R was highly expressed in human monocytic THP-1 cells and that IL-21 induced TLR2 and TLR4 expression and further enhanced PGN/LPS-mediated TLR2/4 expression. In addition, IL-21 also upregulated the expression of IL-6, IL-8, TNF-α, IFN-γ and IL-10 and enhanced TLR2/4-mediated cytokine production in THP-1 cells via phosphorylation of the STAT3, Akt and p38 MAPK signalling pathways. Our study suggests, for the first time that IL-21 enhances TLR2/4-mediated cytokine production in human monocytic THP-1 cells by activating the STAT3, PI3K/Akt and p38 MAPK signalling pathways.
Asunto(s)
Citocinas/biosíntesis , Interleucinas/inmunología , Monocitos/metabolismo , Receptor Toll-Like 2/metabolismo , Receptor Toll-Like 4/metabolismo , Línea Celular Tumoral , Humanos , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , Receptores de Interleucina-21/biosíntesis , Factor de Transcripción STAT3/metabolismo , Transducción de Señal , Células THP-1 , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismoRESUMEN
Neutrophils play key roles in the inflammatory response. The IL-21 cytokine and receptor system is known to be involved in various inflammatory diseases. However, the direct action of IL-21 on neutrophils has not been reported. Here, we show that human neutrophils in peripheral blood express functional IL-21 receptors (IL-21Rs). Expression of the IL-21Rα chain (IL-21Rα) was reduced following various treatments to remove red blood cells, including hypotonic shock, ammonium chloride-mediated lysis, and Percoll density centrifugation. Thus, we utilized whole blood flow cytometric assays to investigate the neutrophil responses to IL-21. IL-21 upregulated the surface expression of CD11b and CD16 on neutrophils and augmented the neutrophils' phagocytic ability. Our data indicated that IL-21 has the potential to enhance the neutrophil functions.
Asunto(s)
Neutrófilos/metabolismo , Receptores de Interleucina-21/biosíntesis , Regulación de la Expresión Génica , Humanos , Leucocitos Mononucleares/metabolismo , Persona de Mediana EdadRESUMEN
Innate immunity to tumors is mediated mainly by natural killer cells (NKs) and dendritic cells (DCs). The function of these cells is coordinated by cytokines produced during the inflammatory process. NK cells are highly active against tumors, being an important source of IFN-γ. Natural killer dendritic cells (NKDCs) were recently identified as a group of hybrid cells; some studies claim that they have lytic activity, produce IFN-γ and can also stimulate antigen-specific T cells. Interleukin 21 (IL-21) regulates the proliferation capacity and cytotoxicity of NK and T cells. The main objective of this study was to investigate if IL-21 influences the frequency of NKDCs in vitro as well as IFN-γ production and also to verify if these cells could enhance the antitumor activity against B16F10 tumor model in vivo. Splenocytes from C57BL/6 mice were isolated and the DC were enriched by immunomagnetic beads and cultured for four days with recombinant IL-21 (10, 20, 40 or 100 ng/ml). NKDC population was characterized as CD11clow/medB220+NK1.1+. Expanded cells were used to treat B16F10 tumor bearing mice and tumor growth was compared between the doses of IL-21 10 ng/ml and 20 ng/ml. The results indicate that IL-21 increases the expansion of splenic NKDCs in vitro in doses of 10 ng/ml and 20 ng/ml and these cells produce IFN-γ. In vivo, cells expanded with IL-21 and injected directly into the growing tumor efficiently reduced the tumor size. Together, these results showed for the first time that IL-21 influences the biology and the effector activity of NKDCs.
Asunto(s)
Citotoxicidad Inmunológica/inmunología , Células Dendríticas/inmunología , Interferón gamma/inmunología , Interleucinas/metabolismo , Células Asesinas Naturales/inmunología , Melanoma/inmunología , Animales , Antígeno CD11c , Línea Celular Tumoral , Proliferación Celular , Interferón gamma/metabolismo , Activación de Linfocitos/inmunología , Ratones , Ratones Endogámicos C57BL , Receptores de Interleucina-21/biosíntesis , Receptores de Interleucina-21/metabolismo , Bazo/inmunologíaRESUMEN
Recently, we reported that IL-21 induces granzyme B (GzmB) and GzmB-dependent apoptosis in malignant CD5(+) B cells from patients with chronic lymphocytic leukemia. Several autoimmune diseases (AD) are associated with enhanced frequencies of CD5(+) B cells. Since AD are also associated with elevated IL-21 and GzmB levels, we postulated a link between CD5(+) B cells, IL-21 and GzmB. Here, we demonstrate that IL-21 and GzmB serum levels are highly correlated in subjects with systemic lupus erythematosus (SLE) and that freshly isolated CD5(+) SLE B cells constitutively express GzmB. IL-21 directly induced GzmB expression and secretion by CD5(+) B cells from several AD and from cord blood in vitro, and the simultaneous presence of BCR stimulation strongly enhanced this process. Furthermore, IL-21 suppressed both viability and expansion of CD5(+) B cells from SLE individuals. In summary, our study may explain the elevated levels of IL-21 and GzmB in SLE and other AD. Moreover, our data suggest that IL-21 may have disease-modifying characteristics by inducing GzmB in CD5(+) B cells and by suppressing their expansion. Our results provide the rationale for further evaluation of the therapeutic potential of IL-21 in certain AD such as SLE.
Asunto(s)
Linfocitos B/metabolismo , Granzimas/metabolismo , Interleucinas/biosíntesis , Lupus Eritematoso Sistémico/inmunología , Receptores de Antígenos de Linfocitos B/metabolismo , Adolescente , Adulto , Anciano , Linfocitos B/inmunología , Linfocitos B/patología , Antígenos CD5/biosíntesis , Proliferación Celular , Supervivencia Celular/inmunología , Femenino , Granzimas/genética , Humanos , Tolerancia Inmunológica , Interleucinas/sangre , Interleucinas/genética , Interleucinas/inmunología , Lupus Eritematoso Sistémico/sangre , Masculino , Persona de Mediana Edad , Receptor Cross-Talk/inmunología , Receptores de Antígenos de Linfocitos B/inmunología , Receptores de Interleucina-21/biosíntesis , Receptores de Interleucina-21/genéticaRESUMEN
IL-21 plays an important role in regulating immune response and controlling chronic viral infections. Recently, we reported its decreased serum concentrations and their immunological consequences in HIV-infected persons. In this study, we have investigated how exogenous IL-21 enhances NK cell responses in these persons. We show that the cytokine receptors are expressed equally on all NK cell subsets defined by expression of CD16 and CD56; the cytokine activates STAT-3, MAPK, and Akt to enhance NK cell functions; the STAT-3 activation plays a key role in constitutive and IL-21-mediated enhancement of NK cell functions; the cytokine increases expression of antiapoptotic proteins Bcl-2 and Bcl-X(L) and enhances viability of NK cells but has no effect on their proliferation; the cytokine enhances HIV-specific ADCC, secretory, and cytotoxic functions, as well as viability of NK cells from HIV-infected persons; it exerts its biological effects on NK cells with minimal stimulation of HIV-1 replication; and the cytokine-activated NK cells inhibit viral replication in cocultured, HIV-infected, autologous CD4(+) T cells in a perforin- and LFA-1-dependent manner. These data suggest that IL-21 may serve as a valuable therapeutic tool for enhancing NK cell responses and inhibiting viral replication in HIV-infected patients.
Asunto(s)
Infecciones por VIH/inmunología , Interleucinas/inmunología , Células Asesinas Naturales/inmunología , Replicación Viral/inmunología , Citotoxicidad Celular Dependiente de Anticuerpos/inmunología , Western Blotting , Linfocitos T CD4-Positivos/inmunología , Separación Celular , Células Cultivadas , Técnicas de Cocultivo , Citometría de Flujo , VIH-1/efectos de los fármacos , VIH-1/fisiología , Humanos , Interleucinas/farmacología , Células Asesinas Naturales/efectos de los fármacos , Receptores de Interleucina-21/biosíntesis , Transducción de Señal/efectos de los fármacos , Transducción de Señal/inmunología , Replicación Viral/efectos de los fármacosRESUMEN
The homeostasis of CD4+ CD25+ regulatory T cells (Tregs) depends on the cytokine interleukin (IL)-2. As IL-21 shares sequence homology with IL-2 and the IL-21 receptors contain a gamma-chain common to IL-2, we hypothesized that IL-21 could also affect the homeostasis of Tregs. We tested this hypothesis in experimental autoimmune encephalomyelitis (EAE), an animal model of relapsing-remitting human multiple sclerosis. We show that blockade of IL-21 in SJL/J mice before and after the induction of EAE enhances the influx of inflammatory cells into the central nervous system (CNS). The blockade of IL-21 leads to proliferation of proteolipid peptide (PLP(139-151))-autoreactive CD4+ T cells, which are capable to cause severe EAE in adoptively transferred recipient mice. Conversely, Tregs from mice where IL-21 was blocked, lose their capacity to prevent EAE induced PLP(139-151)-reactive T cells. Notably, direct effects of IL-21 on Tregs are confirmed by studies of blockade of IL-21 in mice expressing a green fluorescent protein 'knocked' into a Foxp3 allele, in which a reduction of the number of Tregs and a downregulation of their frequency and expression of Foxp3 are observed. These data suggest a role of the IL-21/IL-21R axis in the homeostasis of Tregs in CNS autoimmunity.
Asunto(s)
Encefalomielitis Autoinmune Experimental/inmunología , Homeostasis/inmunología , Interleucinas/fisiología , Linfocitos T Reguladores/inmunología , Secuencia de Aminoácidos , Animales , Encefalomielitis Autoinmune Experimental/metabolismo , Femenino , Homeostasis/genética , Humanos , Fragmentos Fc de Inmunoglobulinas/fisiología , Interleucinas/antagonistas & inhibidores , Interleucinas/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes , Datos de Secuencia Molecular , Receptores de Interleucina-21/biosíntesis , Receptores de Interleucina-21/genética , Transducción de Señal/genética , Transducción de Señal/inmunología , Linfocitos T Reguladores/metabolismoRESUMEN
Interleukin-21 (IL-21) is a newly described cytokine, produced by activated CD4+ T cells. Since the discovery in 2000, IL-21 has been the object of intensive research because of its homology to IL-2, IL-4 and IL-15, and its ability to modulate both innate and adaptive immune responses. IL-21 mediates its functions through a heterodimeric receptor, composed of a specific subunit, termed IL-21 receptor (IL-21R) and the common gamma-chain, that is shared with IL-2, IL-4, IL-7, IL-9, IL-13, and IL-15 receptors. IL-21R is originally described on T, B and NK cells, which is in accordance with the cell types that mostly respond to IL-21. Indeed, IL-21 augments the proliferation of CD4+ and CD8+ T lymphocytes and regulates the profile of cytokines secreted by these cells, drives the differentiation of B cells into memory cells and terminally differentiated plasma cells, and moreover, enhances the activity of natural killer cells. More recently, IL-21R has also been documented on non-immune cells, raising the possibility that IL-21 is an important mediator in the cross-talk between immune and non-immune cells. As discussed in this review, the potential role of IL-21 in immune-mediated and allergic diseases would seem to suggest that either disrupting or enhancing IL-21 signaling may be useful in specific clinical settings.
Asunto(s)
Hipersensibilidad/fisiopatología , Inflamación/fisiopatología , Interleucinas/fisiología , Animales , Gastroenteritis/metabolismo , Gastroenteritis/fisiopatología , Humanos , Hipersensibilidad/metabolismo , Inflamación/metabolismo , Interleucinas/biosíntesis , Interleucinas/genética , Ratones , Receptores de Interleucina-21/biosíntesis , Receptores de Interleucina-21/genéticaRESUMEN
The interleukin 21 (IL-21) receptor is expressed on T-cells, B-cells, and natural killer cells, and IL-21 is critical for regulating immunoglobulin production in vivo in cooperation with IL-4. So far, however, little is known about a role for IL-21 outside the immune system. We investigated the effect of IL-21 on hematopoiesis in vivo by using the hydrodynamics gene-delivery method. Overexpression of IL-21 increases Sca-1+ cells in the periphery and spleen. It also increases the numbers of c-Kit+, Sca-1+, and lineage-/low (KSL) cells and colony-forming units-granulocyte-macrophage (CFU-GM) in the spleen, indicating the expansion of hematopoietic progenitor cells. We found that even in RAG2-/- mice, which lack mature T-cells and B-cells, IL-21 induced an increase in KSL cells and CFU-GM in the spleen. These results demonstrate that IL-21 can induce the expansion of hematopoietic progenitor cells in vivo, even in the absence of mature T-cells and B-cells.